Results

Reset All Filters

Manufacturer:Adooq remove filter

Oncology

Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.

The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.

To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.

Click on the organs and learn more about cancer types

General information

Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.

Relevant products for oncology research

Name	Type	Specific against	Item no.	Amount	Price
CeMMEC1 10mg	Inhibitors	Other	A19900-10 Adooq	10 mg	Login Compare	CeMMEC1 10mg
CeMMEC1 50mg	Inhibitors	Other	A19900-50 Adooq	50 mg	Login Compare	CeMMEC1 50mg
CeMMEC1 100mg	Inhibitors	Other	A19900-100 Adooq	100 mg	Login Compare	CeMMEC1 100mg
CeMMEC1 25mg	Inhibitors	Other	A19900-25 Adooq	25 mg	Login Compare	CeMMEC1 25mg
STAT5-IN-2 1mg	Inhibitors	Other	A20126-1 Adooq	1 mg	Login Compare	STAT5-IN-2 1mg
STAT5-IN-2 5mg	Inhibitors	Other	A20126-5 Adooq	5 mg	Login Compare	STAT5-IN-2 5mg
STAT5-IN-2 10mg	Inhibitors	Other	A20126-10 Adooq	10 mg	Login Compare	STAT5-IN-2 10mg
COX-2-IN-2 1mg	Inhibitors	Other	A20048-1 Adooq	1 mg	Login Compare	COX-2-IN-2 1mg
P-gp modulator 1 1mg	Inhibitors	Other	A20054-1 Adooq	1 mg	Login Compare	P-gp modulator 1 1mg
P-gp modulator 1 5mg	Inhibitors	Other	A20054-5 Adooq	5 mg	Login Compare	P-gp modulator 1 5mg
P-gp modulator 1 10mg	Inhibitors	Other	A20054-10 Adooq	10 mg	Login Compare	P-gp modulator 1 10mg
PI3K/mTOR Inhibitor-1 1mg	Inhibitors	Other	A20055-1 Adooq	1 mg	Login Compare	PI3K/mTOR Inhibitor-1 1mg
PI3K/mTOR Inhibitor-1 5mg	Inhibitors	Other	A20055-5 Adooq	5 mg	Login Compare	PI3K/mTOR Inhibitor-1 5mg
PI3K/mTOR Inhibitor-1 10mg	Inhibitors	Other	A20055-10 Adooq	10 mg	Login Compare	PI3K/mTOR Inhibitor-1 10mg
COX-2-IN-2 5mg	Inhibitors	Other	A20048-5 Adooq	5 mg	Login Compare	COX-2-IN-2 5mg
COX-2-IN-2 10mg	Inhibitors	Other	A20048-10 Adooq	10 mg	Login Compare	COX-2-IN-2 10mg
COX-2-IN-2 50mg	Inhibitors	Other	A20048-50 Adooq	50 mg	Login Compare	COX-2-IN-2 50mg
Hsp90-Cdc37-IN-1 5mg	Inhibitors	Other	A20095-5 Adooq	5 mg	Login Compare	Hsp90-Cdc37-IN-1 5mg
Hsp90-Cdc37-IN-1 10mg	Inhibitors	Other	A20095-10 Adooq	10 mg	Login Compare	Hsp90-Cdc37-IN-1 10mg
PROTAC BET-binding moiety 1 5mg	Inhibitors	Other	A20112-5 Adooq	5 mg	Login Compare	PROTAC BET-binding moiety 1 5mg
PROTAC BET-binding moiety 1 10mg	Inhibitors	Other	A20112-10 Adooq	10 mg	Login Compare	PROTAC BET-binding moiety 1 10mg
SGC-CBP30 5mg	Inhibitors	Other	A13227-5 Adooq	5 mg	Login Compare	SGC-CBP30 5mg
SGC-CBP30 10mg	Inhibitors	Other	A13227-10 Adooq	10 mg	Login Compare	SGC-CBP30 10mg
SGC-CBP30 25mg	Inhibitors	Other	A13227-25 Adooq	25 mg	Login Compare	SGC-CBP30 25mg
SGC-CBP30 50mg	Inhibitors	Other	A13227-50 Adooq	50 mg	Login Compare	SGC-CBP30 50mg

Name Price

CeMMEC1 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19900-10
Amount	10 mg
Available

CeMMEC1 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19900-50
Amount	50 mg
Available

CeMMEC1 100mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19900-100
Amount	100 mg
Available

CeMMEC1 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A19900-25
Amount	25 mg
Available

STAT5-IN-2 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20126-1
Amount	1 mg
Available

STAT5-IN-2 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20126-5
Amount	5 mg
Available

STAT5-IN-2 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20126-10
Amount	10 mg
Available

COX-2-IN-2 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20048-1
Amount	1 mg
Available

P-gp modulator 1 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20054-1
Amount	1 mg
Available

P-gp modulator 1 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20054-5
Amount	5 mg
Available

P-gp modulator 1 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20054-10
Amount	10 mg
Available

PI3K/mTOR Inhibitor-1 1mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20055-1
Amount	1 mg
Available

PI3K/mTOR Inhibitor-1 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20055-5
Amount	5 mg
Available

PI3K/mTOR Inhibitor-1 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20055-10
Amount	10 mg
Available

COX-2-IN-2 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20048-5
Amount	5 mg
Available

COX-2-IN-2 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20048-10
Amount	10 mg
Available

COX-2-IN-2 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20048-50
Amount	50 mg
Available

Hsp90-Cdc37-IN-1 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20095-5
Amount	5 mg
Available

Hsp90-Cdc37-IN-1 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20095-10
Amount	10 mg
Available

PROTAC BET-binding moiety 1 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20112-5
Amount	5 mg
Available

PROTAC BET-binding moiety 1 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A20112-10
Amount	10 mg
Available

SGC-CBP30 5mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A13227-5
Amount	5 mg
Available

SGC-CBP30 10mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A13227-10
Amount	10 mg
Available

SGC-CBP30 25mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A13227-25
Amount	25 mg
Available

SGC-CBP30 50mg

Type	Inhibitors
Clone
Specific against	Other
Appl.
Host
Item no.	A13227-50
Amount	50 mg
Available

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk

REGISTER & SECURE BENEFITS

Filter Results

Oncology

Click on the organs and learn more about cancer types

General information

Relevant products for oncology research

Contact

About Hölzel

Service

Infodesk